Mycoplasma pneumoniae and chlamydia spp. Infection in community-acquired pneumonia, Germany, 2011–2012

Roger Dumke, Christiane Schnee, Mathias W. Pletz, Jan Rupp, Enno Jacobs, Konrad Sachse, Gernot Rohde, M. Dreher, C. Cornelissen, W. Knüppel, I. Armari, D. Stolz, N. Suttorp, H. Schütte, P. Creutz, T. Bauer, T. Weiß, W. Pankow, A. Lies, D. ThiemigB. Hauptmeier, D. Wehde, M. Suermann, S. Ewig, M. Prediger, G. Zernia, G. Höffken, M. Kolditz, T. Welte, G. Barten, M. Abrahamczik, J. Naim, W. Kröner, T. Illig, N. Klopp, C. Kroegel, M. Pletz, M. Pletz, S. Schütz, R. Hörster, G. Rohde, H. Buschmann, R. Kröning, T. Schaberg, I. Hering, C. Schumann, T. Illmann, the CAPNETZ Study Group, M. Wallner

38 Zitate (Scopus)

Abstract

Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CAP), are diffcult to propagate, and can cause clinically indistinguish able disease patterns. During 2011-2012, we used molecu lar methods to test adult patients in Germany with confrmed CAP for infection with these 2 pathogens. Overall, 12.3% (96/783) of samples were positive for M. pneumoniae and 3.9% (31/794) were positive for Chlamydia spp.; C. psittaci (2.1%) was detected more frequently than C. pneumoniae (1.4%). M. pneumoniae P1 type 1 predominated, and lev els of macrolide resistance were low (3.1%). Quarterly rates of M. pneumoniae-positive samples ranged from 1.5% to 27.3%, showing a strong epidemic peakforthese infections, but of Chlamydia spp. detection was consistent throughout the year. M. pneumoniae-positive patients were younger and more frequently female, had fewer co-occurring condi tions, and experienced milder disease than did patients who tested negative. Clinicians should be aware of the epidemi- ology of these pathogens in CAP.
OriginalspracheEnglisch
ZeitschriftEmerging Infectious Diseases
Jahrgang21
Ausgabenummer3
Seiten (von - bis)426-434
Seitenumfang9
ISSN1080-6040
DOIs
PublikationsstatusVeröffentlicht - 01.01.2015

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

DFG-Fachsystematik

  • 2.21-03 Medizinische Mikrobiologie und Mykologie, Hygiene, Molekulare Infektionsbiologie
  • 2.21-05 Immunologie
  • 2.22-13 Pneumologie, Thoraxchirurgie
  • 2.22-02 Public Health, gesundheitsbezogene Versorgungsforschung, Sozial- und Arbeitsmedizin
  • 2.22-31 Klinische Infektiologie und Tropenmedizin

Fingerprint

Untersuchen Sie die Forschungsthemen von „Mycoplasma pneumoniae and chlamydia spp. Infection in community-acquired pneumonia, Germany, 2011–2012“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren